🇺🇸 FDA
Patent

US 10087156

Methods and compositions related to retinoid receptor-selective pathway

granted A61KA61K38/191A61P

Quick answer

US patent 10087156 (Methods and compositions related to retinoid receptor-selective pathway) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/191, A61P, A61P35/00, A61P43/00